Department of Medicine, Chung-Shan Medical University, Taichung 40201, Taiwan.
Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Int J Mol Sci. 2022 Jan 26;23(3):1407. doi: 10.3390/ijms23031407.
Acute flares (AFs) of chronic hepatitis B usually occur during the immune-active stage (both immune clearance phase and immune reactivation phase), as the host immune system tries to control the virus. Successful host immune control over viral replication is usually presented as hepatitis B surface antigen seroclearance; however, 20-30% individuals with chronic hepatitis B may encounter repeated AFs with accumulative liver injuries, finally leading to the development of cirrhosis and hepatocellular carcinoma. AF can also develop in other clinical situations such as organ transplantation, cancer chemotherapy, and under treatment for chronic hepatitis B or treatment for chronic hepatitis C in patients with co-infected hepatitis B/hepatitis C. Understanding the natural history and immunopathogenesis of AF would help develop effective strategies to eradicate the virus and improve the clinical outcomes of patients with chronic hepatitis B. In this review article, the immunopathogenesis of AF, and the involvement of innate and adaptive immune responses on the development of hepatitis B flare will be briefly reviewed, with the emphasis on the role of cytokines and chemokines.
慢性乙型肝炎的急性发作(AFs)通常发生在免疫活跃期(免疫清除期和免疫再激活期),此时宿主免疫系统试图控制病毒。宿主对病毒复制的成功免疫控制通常表现为乙型肝炎表面抗原血清学清除;然而,20-30%的慢性乙型肝炎患者可能会反复出现急性发作,累积肝脏损伤,最终导致肝硬化和肝细胞癌的发展。AF 也可能发生在其他临床情况下,如器官移植、癌症化疗,以及慢性乙型肝炎的治疗或慢性乙型肝炎/丙型肝炎合并感染患者的慢性丙型肝炎治疗。了解 AF 的自然史和免疫发病机制有助于制定有效的策略来根除病毒,改善慢性乙型肝炎患者的临床结局。在这篇综述文章中,我们将简要回顾 AF 的免疫发病机制,以及固有和适应性免疫反应在乙型肝炎发作发展中的作用,重点介绍细胞因子和趋化因子的作用。